HighTide Therapeutics Inc. announced the appointment of Edmund Sim as chief financial officer (CFO). Mr. Sim will report to Dr. Liping Liu, Founder and CEO of HighTide. Mr. Sim has been in the field of investment and financing for over 20 years in US and China.

Prior to HighTide, he worked in a contract research organization and led the international business development and fundraising exercise. Mr. Sim has extensive capital markets experience with global investment banks in US and China. At HighTide, he will be responsible for the group financing and capital market activities.

In addition, he will play a key role in global business strategy and corporate development. During his tenure, Mr. Sim joined Vitasky Research as the general manager of the International Business and group VP which completed numerous rounds of pre-IPO financings and set up overseas laboratories in Melbourne, Australia. Prior, he worked for China Merchant Securities International, BofA Securities, Goldman Sachs, Citigroup, Bank of China International who manage 100 plus employees and successfully completed more than 130 IPO projects globally.

Mr. Sim holds a Bachelor of Business Degree in Queensland University of Technology, Master of Science in Financial Management in University of London and CPA qualification in Hong Kong.